American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th ed. American Psychiatric Association, Washington, DC. Blazer, D. G., Kessler, R. C., McGonagle, K. A., and Swartz, M. S. (1994). The prevalence and distribution of major depression in a national community sample: The National Comorbidity Survey. Am. J. Psychiatr. 151, 979-986. Consensus Development Panel (1985). Mood disorders: Pharama-cologic prevention of recurrences. Am. J. Psychiatr. 142, 469-476.
Consensus Development Panel (1986). Report on the NIMH-NIH Consensus Development Conference on electroconvulsive therapy. Psychopharmacol. Bull. 22, 445-502.
DeRubeis, R. J., and Crits-Cristoph, P. (1998). Empirically supported individual and group psychological treatments for adult mental disorders. J. Consulting Clin. Psychol. 66, 37-52.
Elkin, I., Shea, M. T., Watkins, J. T., Imber, S. D., Sotsky, S. M., Collins, J. F., Glass, D. R., Pilkonis, P. A., Leber, W. R., Docherty, J. P., Fiester, S. J., and Parloff, M. B. (1989). National Institute of Mental Health treatment of depression collaborative research program. Arch. Gen. Psychiatr. 46, 971-982.
Fava, G. A., Rafanelli, C., Grandi, S., Canestrari, R., and Morphy, M. A. (1998). Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am. J. Psychiatr. 155, 1443-1445.
Horst, W. D., and Preskorn, S. H. (1998). Mechanism of action and clinical characteristics of three atypical antidepressants: Venla-faxine, nefazodone, buproprion. J. Affective Disorders 51, 237-254.
Keitner, G. I., and Miller, I. W. (1990). Family functioning and major depression: An overview. Am. J. Psychiatr. 147, 1128-1137.
Keller, M. B., McCullough, J. P., Klein, D. N., Arnow, B., Dunner, D. L., Gelenberg, A. J., Markowitz, J. C., Nemeroff, C. B., Russell, J. M., Thase, M. E., Trivedi, M. H., and Zajecka, J.
(2000). A comparison of nefazodone, the cognitive-behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N. Engl. J. Med. 342, 1462-1470.
Kessler, R. C., Nelson, C. B., McGonagle, K. A., Liu, J., Swartz, M., and Blazer, D. G. (1996). Comorbidity of DSM-III-R major depressive disorder in the general population: Results from the National Comorbidity Survey. Br. J. Psychiatr. 168(Suppl. 30), 17-30.
Luborsky, L., Mark, D., Hole, A. V., Popp, C., Goldsmith, B., and Cacciola, J. (1995). Supportive-expressive dynamic psychotherapy of depression: A time-limited version. In Dynamic Therapies for Psychiatric Disorders (Axis I). (J. Barber and P. Crits-Cristoph, Eds.). Basic Books, New York.
Mesulam, M. M. (2000). Principles of Behavioral and Cognitive Neurology, 2nd ed. Oxford Univ. Press, Oxford.
Paykel, E. S., Scott, J., Teasdale, J. D., Johnson, A. L., Garland, A., Moore, R., Jenaway, A., Cornwall, P. L., Hayhurst, H., Abbott, R., and Pope, M. (1999). Prevention of relapse in residual depression by cognitive therapy. Arch. Gen. Psychiatr. 56, 829-835.
Stahl, S. M. (1998). Mechanism of action of serotonin selective reuptake inhibitors: Serotonin receptors and pathways mediate therapeutic effects and side effects. J. Affective Disorders 51, 215-228.
Was this article helpful?
Finally, Retired Clinical Counsellor Reveals the Secrets Successful Psychiatrists and Psychologists Don't Want You to Know. How to Stop Your Depression Now Reclaim Yourself and Live Again Get the Depression Busting Tools You Need To Win the War Against Depression. Depression is an illness that many people often sweep under a rug. However if depression is left untreated... Your life can become a living nightmare. Depression is a growing epidemic in the US, but it never gets the urgent attention it deserves. You need help and you need it now.